These HLA-A24 ligands were possibly overexpressed in tumor samples and were therefore chosen as nonmutated TAA candidates of CRC111, which comprised peptides encoded by the KLK8, DEFA3, STRIP2, MMP1, FSCN1, TBX15, and PHLDA1 genes (Supplemental Table 3). The gene discussed is FSCN1; the disease is neoplasm.